Cargando…
PD-L1 Expression Fluctuates Concurrently with Cyclin D in Glioblastoma Cells
Despite Glioblastoma (GBM) frequently expressing programmed cell death ligand-1 (PD-L1), treatment with anti-programmed cell death-1 (PD1) has not yielded brilliant results. Intratumor variability of PD-L1 can impact determination accuracy. A previous study on mouse embryonic fibroblasts (MEFs) repo...
Autores principales: | Tufano, Martina, D’Arrigo, Paolo, D’Agostino, Massimo, Giordano, Carolina, Marrone, Laura, Cesaro, Elena, Romano, Maria Fiammetta, Romano, Simona |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8468141/ https://www.ncbi.nlm.nih.gov/pubmed/34572014 http://dx.doi.org/10.3390/cells10092366 |
Ejemplares similares
-
Scaffold proteins of cancer signaling networks: The paradigm of FK506 binding protein 51 (FKBP51) supporting tumor intrinsic properties and immune escape
por: MARRONE, LAURA, et al.
Publicado: (2023) -
Eradication of CSCs: the roadmap for curing cancer
por: Romano, Simona, et al.
Publicado: (2020) -
The splicing FK506-binding protein-51 isoform plays a role in glioblastoma resistance through programmed cell death ligand-1 expression regulation
por: D’Arrigo, Paolo, et al.
Publicado: (2019) -
FKBP51 Affects TNF-Related Apoptosis Inducing Ligand Response in Melanoma
por: Tufano, Martina, et al.
Publicado: (2021) -
A regulatory role for the co-chaperone FKBP51s in PD-L1 expression in glioma
por: D’Arrigo, Paolo, et al.
Publicado: (2017)